Bidness Etc |
GSK's Asthma Treatment Gets FDA Approval
Bidness Etc Yesterday, GlaxoSmithKline plc (GSK) announced that the Food and Drug Administration (FDA) has given marketing approval for its drug Arnuity Ellipta, developed as an asthma treatment in patients aged 12 and older. Asthma is a lingering lung disease … FDA OKs New Maintenance Asthma Treatment Arnuity Ellipta FDA approves GSK asthma medicine FDA approves GSK's Arnuity Ellipta for treating asthma |
View full post on asthma – Google News